Alvotech Advances in Biosimilar Market with Successful AVT03 Study
Alvotech SA, a global biotech company from Luxembourg, specialising in biosimilars, reported positive results from a pharmacokinetic study of AVT03,...
Production process for cell-based coffee published
Given the high environmental costs of producing 10 million tonnes of coffee per year, scientists have been considering biotechnological production...
Cathera SA closes Series B round at €42m
The Series B update was led by Unorthodox Ventures. Existing shareholders Supernova Invest, Saint-Genys and Bouscas Med also participated in the...
German companies to revolutionise lab plastics market
Plastic consumables used in pharmaceutical and biotechnological research must meet high quality standards. A German start-up has now launched the...
Bayer's Ask Bio unit starts Phase II heart failure gene therapy
The Phase II trial called GenePHIT is the largest adaptive, double-blind, placebo-controlled, randomised, multicentre trial ever to evaluate the...
Boehringer Ingelheim enters €410m licence deal with Kyowa Kirin Co., Ltd.
Under the terms of a new licencing and co-development deal, Boehringer Ingelheim will receive the exclusive, worldwide rights from Kyowa Kirin to...
Germany blocks deregulation of NGT breeds
The Spanish EU Council Presidency wanted to speed up a decision on the new regulation that foresees to allow a faster market approval of breeds made...